Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Accumulated Expenses (2016 - 2026)

Apyx Medical filings provide 16 years of Accumulated Expenses readings, the most recent being $8.2 million for Q4 2025.

  • On a quarterly basis, Accumulated Expenses rose 5.97% to $8.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.2 million, a 5.97% increase, with the full-year FY2025 number at $8.2 million, up 5.97% from a year prior.
  • Accumulated Expenses hit $8.2 million in Q4 2025 for Apyx Medical, up from $7.3 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $10.3 million in Q4 2021 to a low of $6.8 million in Q1 2025.
  • Median Accumulated Expenses over the past 5 years was $7.9 million (2023), compared with a mean of $8.1 million.
  • Biggest five-year swings in Accumulated Expenses: soared 41.34% in 2021 and later decreased 19.77% in 2024.
  • Apyx Medical's Accumulated Expenses stood at $10.3 million in 2021, then decreased by 13.21% to $8.9 million in 2022, then rose by 8.21% to $9.7 million in 2023, then decreased by 19.77% to $7.8 million in 2024, then grew by 5.97% to $8.2 million in 2025.
  • The last three reported values for Accumulated Expenses were $8.2 million (Q4 2025), $7.3 million (Q3 2025), and $7.3 million (Q2 2025) per Business Quant data.